543 related articles for article (PubMed ID: 17671192)
1. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
[TBL] [Abstract][Full Text] [Related]
2. Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.
Horak CE; Mendoza A; Vega-Valle E; Albaugh M; Graff-Cherry C; McDermott WG; Hua E; Merino MJ; Steinberg SM; Khanna C; Steeg PS
Cancer Res; 2007 Dec; 67(24):11751-9. PubMed ID: 18089805
[TBL] [Abstract][Full Text] [Related]
3. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
[TBL] [Abstract][Full Text] [Related]
4. Expression of nm23-H1 in uveal melanoma.
Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
Ouatas T; Halverson D; Steeg PS
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169
[TBL] [Abstract][Full Text] [Related]
6. Downstream targets of Nm23-H1: gene expression profiling of CAL 27 cells using DNA microarray.
Bosnar MH; Bago R; Gall-Troselj K; Streichert T; Pavelić J
Mol Carcinog; 2006 Aug; 45(8):627-33. PubMed ID: 16739125
[TBL] [Abstract][Full Text] [Related]
7. Double mutant P96S/S120G of Nm23-H1 abrogates its NDPK activity and motility-suppressive ability.
Zhou Q; Yang X; Zhu D; Ma L; Zhu W; Sun Z; Yang Q
Biochem Biophys Res Commun; 2007 May; 356(2):348-53. PubMed ID: 17335772
[TBL] [Abstract][Full Text] [Related]
8. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].
Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF
Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527
[TBL] [Abstract][Full Text] [Related]
9. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS
Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805
[TBL] [Abstract][Full Text] [Related]
10. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity.
Leone A; Flatow U; VanHoutte K; Steeg PS
Oncogene; 1993 Sep; 8(9):2325-33. PubMed ID: 8395676
[TBL] [Abstract][Full Text] [Related]
11. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
[TBL] [Abstract][Full Text] [Related]
12. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
[TBL] [Abstract][Full Text] [Related]
13. Alteration in gene expression profile and biological behavior in human lung cancer cell line NL9980 by nm23-H1 gene silencing.
Ma W; Chen J; Xue X; Wang Z; Liu H; Wang T; Bai Y; Tang SC; Zhou Q
Biochem Biophys Res Commun; 2008 Jul; 371(3):425-30. PubMed ID: 18440302
[TBL] [Abstract][Full Text] [Related]
14. Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metastatic potential.
Liu F; Zhang Y; Zhang XY; Chen HL
J Cancer Res Clin Oncol; 2002 Apr; 128(4):189-96. PubMed ID: 11935309
[TBL] [Abstract][Full Text] [Related]
15. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells.
Boissan M; De Wever O; Lizarraga F; Wendum D; Poincloux R; Chignard N; Desbois-Mouthon C; Dufour S; Nawrocki-Raby B; Birembaut P; Bracke M; Chavrier P; Gespach C; Lacombe ML
Cancer Res; 2010 Oct; 70(19):7710-22. PubMed ID: 20841469
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
17. Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells.
Liu F; Qi HL; Chen HL
J Cancer Res Clin Oncol; 2000 Feb; 126(2):85-90. PubMed ID: 10664247
[TBL] [Abstract][Full Text] [Related]
18. Nm23 and tumour metastasis: basic and translational advances.
Freije JM; MacDonald NJ; Steeg PS
Biochem Soc Symp; 1998; 63():261-71. PubMed ID: 9513729
[TBL] [Abstract][Full Text] [Related]
19. [nm23-H1 gene inhibits lung cancer cell invasion through down-regulation of PKC signal pathway].
Nie Q; Zhou QH; Zhu W; Liu LX; Fu JK; Li DB; Li Y; Che GW
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):334-6. PubMed ID: 17044994
[TBL] [Abstract][Full Text] [Related]
20. [Influence of estrogen and progestin on nm23-H1 expression in epithelial ovarian cancer cell lines via activation of phosphorylation signaling].
Hua KQ; Yao LQ; Cao Q; Huang Y; Zhao YQ; Feng YJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):756-61. PubMed ID: 17327034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
